Global Cosmetics Company Sponsored Symposium on Skin Barriers and Skin Redness Among Renowned Dermatologists DALLAS–(BUSINESS WIRE)–Nov. 11, 2019 As a[…]
Read more
Category: Biomedical
Promethera Biosciences: Announcement Regarding Business Activities in Japan
MONT-SAINT-GUIBERT, Belgium & TOKYO–(BUSINESS WIRE)–Oct. 31, 2019 Promethera Biosciences SA (Group), a global innovator in cell-based medicines and liver diseases,[…]
Read more
Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas
Hansoh Pharma to innovate using artificial intelligence (AI) technology to generate first in-class and best in-class small molecules. SHANGHAI &[…]
Read more
Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA
NEW YORK–(BUSINESS WIRE)–Sep. 09, 2019 Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of[…]
Read more
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
NEW YORK–(BUSINESS WIRE)–Sep. 09, 2019 Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of[…]
Read more
ESC: Providing Asian doctors with the Very Latest in Cardiovascular Science
SINGAPORE–(BUSINESS WIRE)–Jul. 18, 2019 A new congress to improve patient care. 8 to 10 November in Singapore How can physicians[…]
Read more
Terns Pharmaceuticals Appoints Ankang Li Ph.D. J.D. CFA as Chief Financial Officer
FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–Jul. 01, 2019 Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing[…]
Read more
Takeda Completes Sale of Xiidra® to Novartis
OSAKA, Japan–(BUSINESS WIRE)–Jul. 01, 2019 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its sale of its[…]
Read more
Terns Pharmaceuticals Initiates a Phase 1 Clinical Trial of TERN-101
Phase 1 study will evaluate the safety and tolerability of TERN-101, an FXR agonist in development for the treatment of[…]
Read more
Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma
TOKYO–(BUSINESS WIRE)–Jun. 05, 2019 Otsuka Chemical Co., Ltd. (Head office: Chuo-Ku, Osaka; President & Representative Director: Takeharu Harashima; hereinafter “Otsuka[…]
Read more